Registration - In-house Corporation

Eli Lilly Canada Inc. / Kenneth L Custer, President and General Manager

Registration Information

In-house Corporation name: Eli Lilly Canada Inc.
Responsible Officer Name: Kenneth L Custer, President and General Manager
Responsible Officer Change History
Initial registration start date: 2005-12-19
Registration status: Active
Registration Number: 954779-6034

Associated Communications

Total Number of Communication Reports: 133

Monthly communication reports in the last 6 months: 8

Version 33 of 34 (2024-02-01 to 2024-05-13)

Registration versions:

Version 33 of 34 (2024-02-01 to 2024-05-13)

Lobbying Information

Subject Matters

Economic Development
Health
Industry
Intellectual Property
International Trade
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Legislative Proposal, Bill or Resolution

Food and Drug Act - An Act respecting food, drugs, cosmetics and therapeutic devices. Discussions relating to progressive licensing and the modernization of the Food and Drug Act.
Patent Act - An Act respecting patents of invention with regard to Intellectual Property Protection for pharmaceutical products - federal court decisions that have changed the disclosure requirements regarding the utility of an invention.

Policies or Program

Free trade treaty agreement as it relates to the North American Free Trade Agreement (NAFTA) and free trade negotiations as it relates to Columbia, India, and the European Union
Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.
Pharmaceutical pricing policy arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry

Regulation

Intellectual Property - Changes to Patented Medicine (Notice of Compliance) (PMNOC) regulations - important regulations that can affect Eli Lilly Canada's business
Patented Medicine Notice of Compliance (PMNOC) Regulations - enforcement of Intellectual Property with respect to the Canadian pharmaceutical industry.
Patented Medicines Pricing Review Board (PMPRB) – regulations that can impact the Canadian pharmaceutical industry.

Communication Techniques

Written communication
Oral communication

Government Institutions

Agriculture and Agri-Food Canada (AAFC)
Federal Economic Development Agency for Southern Ontario (FedDev)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Great Lakes Pilotage Authority
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Invest in Canada Hub
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Health Agency of Canada (PHAC)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)

In-house Corporation Details

Description of activities

Pharmaceutical manufacturer, research and development, commercial operations.

Responsible officer name and position during the period of this registration

Kenneth L Custer, President and General Manager

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
P. O. Box 73, Exchange Tower
130 King Street West, Suite 900
Toronto, ON M5X 1B1
Canada

Telephone number: 416-699-7222
Fax number: 416-694-0487

Parent Company Information

Eli Lilly & Company
- Lilly Corporate Center
  Indianapolis, IN 46225
  United States of America

Subsidiary Beneficiary Information

Eli Lilly Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Kenneth L Custer, President and General Manager | No public offices held
Jill Daley, General Counsel & Vice-President Corporate Affairs | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Christopher Praught, Sr. Manager, Policy & Government Relations, Corporate Affairs | Designated public offices held

Eli Lilly Canada Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Eli Lilly Canada Inc.	2024-05-13	current
Eli Lilly Canada Inc.	2009-07-06	2024-05-13

The following names have been used before July 2, 2008

Eli Lilly Canada Inc.

Eli Lilly Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Kenneth L Custer	2023-05-01	Current
Rhonda Pacheco	2020-02-01	2023-05-01
Lisa Matar	2013-06-04	2020-02-01
Michael Mason	2012-10-02	2013-06-04
David Ricks	2005-12-19	2012-10-02

Kenneth L Custer, President and General Manager (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-133 of 133

Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yash Nanda, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2024-04-22
Posted date: 2024-05-15
Communication number: 6034-603127 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Ciesielski, Manager, Office of Patented Medicines and Liaison | Health Canada (HC)
- Anne Bowes, Director | Health Canada (HC)
- David Lee, Chief Regulatory Officer | Health Canada (HC)
- Paul Brogan, Market Director | Invest in Canada Hub
- Erin Campbell, Director | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2024-02-26
Posted date: 2024-03-15
Communication number: 6034-595827 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Norris, Senior Trade Policy Officer | Global Affairs Canada (GAC)
- Loris Mirella, Director | Global Affairs Canada (GAC)
Subject Matter of the communication: Health
Communication date: 2024-01-31
Posted date: 2024-02-15
Communication number: 6034-592233 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
- Caroline Menard, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2024-01-23
Posted date: 2024-02-15
Communication number: 6034-592232 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yash Nanda, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2024-01-23
Posted date: 2024-02-15
Communication number: 6034-592230 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eshan Naik, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2024-01-23
Posted date: 2024-02-15
Communication number: 6034-592192 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Brogan, Market Director | Invest in Canada Hub
- Abbigael Loomis , Investor Services Associate | Invest in Canada Hub
Subject Matter of the communication: Economic Development
Communication date: 2023-12-18
Posted date: 2024-01-15
Communication number: 6034-589882 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ophelia John, Senior Policy Advisor | Health Canada (HC)
- Eshan Naik, Director of Policy | Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-12-14
Posted date: 2024-01-15
Communication number: 6034-589881 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eshan Naik, Director of Policy | Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-10-06
Posted date: 2023-11-15
Communication number: 6034-581797 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marie-Elisabeth Lebrun, Director | Health Canada (HC)
- Linsey Hollett, Assistant Deputy Minister | Health Canada (HC)
- Greg Loyst, Director General | Health Canada (HC)
- Stefania Trombetti, Assistant Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-08-01
Posted date: 2023-09-15
Communication number: 6034-576324 (amended from 6034-576323) View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Melissa Lantsman, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2023-05-24
Posted date: 2023-06-15
Communication number: 6034-567899 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Suzanne McGurn, President and CEO | CADTH | Health Canada (HC)
- Eric Belair , Associate Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
- Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2023-03-09
Posted date: 2023-04-15
Communication number: 6034-562097 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kyle Seeback , Member of Parliament | House of Commons
- Ben Martin, Member's Assistant | House of Commons
Subject Matter of the communication: International Trade
Communication date: 2022-12-05
Posted date: 2023-01-16
Communication number: 6034-553277 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
- Kasondra White, Director | Innovation, Science and Economic Development Canada (ISED)
- Samir Chhabra, Officer | Innovation, Science and Economic Development Canada (ISED)
- Darryl Patterson, Departmental Liaison Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: International Trade
Communication date: 2022-12-01
Posted date: 2023-01-16
Communication number: 6034-553276 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Nicolas Lesieur, Senior Trade Policy Officer | Global Affairs Canada (GAC)
- Clarissa Allen, Trade Policy Officer | Global Affairs Canada (GAC)
- Loris Mirella, Director | Intellectual Property Trade | Global Affairs Canada (GAC)
Subject Matter of the communication: International Trade
Communication date: 2022-11-30
Posted date: 2022-12-15
Communication number: 6034-549927 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mary Ng, Minister of International Trade, Export Promotion, Small Business and Economic Development | Global Affairs Canada (GAC)
Subject Matter of the communication: International Trade
Communication date: 2022-11-23
Posted date: 2022-12-15
Communication number: 6034-549924 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health
Communication date: 2022-10-27
Posted date: 2022-11-15
Communication number: 6034-546208 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-09-28
Posted date: 2022-10-15
Communication number: 6034-542866 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Eric Costen, Senior Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-08-25
Posted date: 2022-09-15
Communication number: 6034-541288 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, International Trade
Communication date: 2022-06-28
Posted date: 2022-07-15
Communication number: 6034-537379 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health
Communication date: 2022-05-24
Posted date: 2022-06-15
Communication number: 6034-534272 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-05-19
Posted date: 2022-06-15
Communication number: 6034-534270 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Samir Khan, Director | Strategic Policy Branch | Health Canada (HC)
- Michelle Boudreau, Executive Director | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-05-16
Posted date: 2022-06-15
Communication number: 6034-534268 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health
Communication date: 2022-04-07
Posted date: 2022-05-16
Communication number: 6034-531020 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Sebastien Bock, Director of Policy | Minister of Health, Minister's Office | Health Canada (HC)
- Sandenga Yeba, Senior Policy Advisor | Minister of Health, Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-04-04
Posted date: 2022-05-16
Communication number: 6034-531021 (amended from 6034-531018) View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-03-31
Posted date: 2022-04-16
Communication number: 6034-527904 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Darryl Patterson, Director General | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-03-29
Posted date: 2022-04-16
Communication number: 6034-527901 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Boudreau, Executive Director, | Strategy Policy Branch, Office of Pharmaceutical Management Strategies | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2022-03-29
Posted date: 2022-04-16
Communication number: 6034-527900 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-03-17
Posted date: 2022-04-16
Communication number: 6034-527866 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bianca Hossain, Sr Special Assistant | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2022-01-27
Posted date: 2022-02-15
Communication number: 6034-521400 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dylan Marando, Senior Policy Advisor | Policy and Cabinet Affairs | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2021-08-03
Posted date: 2021-09-15
Communication number: 6034-513871 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Patrick Weiler, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-07-08
Posted date: 2021-08-16
Communication number: 6034-512444 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-06-15
Posted date: 2021-07-15
Communication number: 6034-510029 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-06-10
Posted date: 2021-07-15
Communication number: 6034-510028 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marcus Powlowski, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2021-05-27
Posted date: 2021-06-15
Communication number: 6034-506913 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jacqueline Arthur, Sr Manager, Policy Development, AMR Division | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
- Bersabel Ephrem, Director General | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
- Niyi Lawuyi, Advisor to Director General | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2021-02-01
Posted date: 2021-03-15
Communication number: 6034-497966 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Boyan Gerasimov, Director of Policy | Office of the Minister, Minister of Public Services and Procurement Canada | Public Services and Procurement Canada (PSPC)
- Sheryl Groeneweg, Director General | Director's General Office, Manufacturing and Life Sciences Branch, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2021-01-28
Posted date: 2021-02-15
Communication number: 6034-495107 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jacqueline Arthur, Sr Manager, Policy Development, AMR Division | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
- Jennifer Siushansian, Public Health Advisor | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
- Niyi Lawuyi, Advisor to Director General | Director General's Office - Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2020-12-16
Posted date: 2021-02-11
Communication number: 6034-495116 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Arianne Reza, Assistant Deputy Minister, Procurement | ADM - Procurement Branch, Acquisitions Program | Public Services and Procurement Canada (PSPC)
- Roman Szumski, Senior Vice President | Sr VP's office, Vaccine Acquisition Branch | Public Health Agency of Canada (PHAC)
Subject Matter of the communication: Health
Communication date: 2020-12-08
Posted date: 2021-02-11
Communication number: 6034-495112 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health
Communication date: 2020-10-22
Posted date: 2020-11-16
Communication number: 6034-486812 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director of Policy at Office of the Minister of Health | Health Canada (HC)
- Rick Theis, Director of Policy and Cabinet Affairs | Prime Minister's Office (PMO)
- Bud Sambasivam, Senior Policy Advisor | Deputy Prime Minister and Minister of Intergovernmental Affairs | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2020-10-20
Posted date: 2020-11-16
Communication number: 6034-486679 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health
Communication date: 2020-10-07
Posted date: 2020-11-16
Communication number: 6034-486680 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director of Policy | Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2020-09-17
Posted date: 2020-10-09
Communication number: 6034-483443 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Matthew Jeneroux, Member of Parliament | House of Commons | House of Commons
Subject Matter of the communication: Health
Communication date: 2020-06-23
Posted date: 2020-07-14
Communication number: 6034-477639 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Doug Clark, Executive Director | PMPRB | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health
Communication date: 2020-06-05
Posted date: 2020-07-14
Communication number: 6034-477638 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Research and Development
Communication date: 2020-05-15
Posted date: 2020-06-15
Communication number: 6034-475700 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
- Supriya Sharma, Chief Medical Advisor, HC | Health Products and Food Branch | Health Canada (HC)
- Celia Lourenco, Director General, Biologics and Genetic Therapies Directorate | Health Products and Food Branch | Health Canada (HC)
- J Patrick Stewart, Director General, Therapeutic Products Directorate | Health Products and Food Branch | Great Lakes Pilotage Authority
- Greg Loyst, Director General, Policy and Regulatory Strategies | Regulatory, Operations and Enforcement Branch | Health Canada (HC)
- Gina Charos, Director General | Infectious Disease Prevention and Control Branch | Public Health Agency of Canada (PHAC)
- Sheryl Groeneweg, Director General | Manufacturing and Life Sciences Branch, Industry Sector | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development
Communication date: 2020-04-16
Posted date: 2020-05-14
Communication number: 6034-472369 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steve Verheul, Assistant Deputy Minister | Trade Policy and Negotiations | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Intellectual Property, Research and Development
Communication date: 2020-03-06
Posted date: 2020-04-15
Communication number: 6034-471094 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry
Communication date: 2019-05-29
Posted date: 2019-06-11
Communication number: 6034-454844 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bill Blair, Minister of Border Security and Organized Crime Reduction | House of Commons | House of Commons
Subject Matter of the communication: Health
Communication date: 2019-05-24
Posted date: 2019-06-14
Communication number: 6034-455781 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Kovacecvic, Assistant Deputy Minister | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)
- Suzy Mccdonald, Associate Assistant Deputy Minister | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)
Subject Matter of the communication: Health, Industry
Communication date: 2019-03-11
Posted date: 2019-03-18
Communication number: 6034-448302 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | PMPRB | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2019-03-07
Posted date: 2019-03-18
Communication number: 6034-448304 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sheryl Groeneweg, Director General | Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Science and Technology, Economic Development
Communication date: 2019-01-16
Posted date: 2019-01-28
Communication number: 6034-444256 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bill Blair, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Research and Development
Communication date: 2018-12-17
Posted date: 2019-01-15
Communication number: 6034-443750 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Economic Development
Communication date: 2018-12-04
Posted date: 2019-01-13
Communication number: 6034-443517 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Guy Foregeron, Assistant Secretary, Regulatory Affairs Sector | Treasury Board | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Health, Industry, International Trade, Research and Development
Communication date: 2018-11-14
Posted date: 2018-11-19
Communication number: 6034-439848 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry
Communication date: 2018-10-25
Posted date: 2018-11-01
Communication number: 6034-436876 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Daniel Albas, Opposition on Innovation, Science and Economic Developement Critic | House of Commons
Subject Matter of the communication: Health, Research and Development
Communication date: 2018-10-23
Posted date: 2018-11-09
Communication number: 6034-437545 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gianluca Cairo, Chief of Staff to Minister Bains | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development
Communication date: 2018-10-23
Posted date: 2018-11-09
Communication number: 6034-437542 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Knubley, Deputy Minister, ISED | ISED | Innovation, Science and Economic Development Canada (ISED)
- Mark Schaan, Director General, Market Framework Policy branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development
Communication date: 2018-10-23
Posted date: 2018-11-09
Communication number: 6034-437537 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Director General | Marketplace Framework, Policy Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2018-10-03
Posted date: 2018-11-01
Communication number: 6034-436875 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry
Communication date: 2018-09-11
Posted date: 2018-09-28
Communication number: 6034-434203 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | PMPRB | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-07-17
Posted date: 2018-08-13
Communication number: 6034-432191 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | PMPRB | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-06-27
Posted date: 2018-08-13
Communication number: 6034-432193 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hilary Travis, Policy Advisor, Office of the Minister of Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development, Economic Development
Communication date: 2018-06-11
Posted date: 2018-06-14
Communication number: 6034-428735 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maximilien Roy, Policy Advisor Office of the Minister of Finance | Finance Canada (FIN)
Subject Matter of the communication: Health, Research and Development, Economic Development
Communication date: 2018-06-11
Posted date: 2018-06-14
Communication number: 6034-428726 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Policy Director | Health Policy | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2018-06-11
Posted date: 2018-06-14
Communication number: 6034-428679 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicines Review Board | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Economic Development
Communication date: 2018-05-17
Posted date: 2018-08-13
Communication number: 6034-428683 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry
Communication date: 2018-04-10
Posted date: 2018-04-12
Communication number: 6034-423574 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Abby Hoffman, Assistant Deputy Minister | Strategic Policy | Health Canada (HC)
- Eric Dagenais, Assistant Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Simon Kennedy, Deputy Minister | Health Canada (HC)
- John Knubley, Deputy Minister | Innovation, Science and Economic Development Canada (ISED)
- Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
- David MacFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
- Genevieve Hinse, Chief of Staff | Health Canada (HC)
- Kathryn Nowers, Director of Policy | Health Canada (HC)
- Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2018-04-03
Posted date: 2018-04-13
Communication number: 6034-424116 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health
Communication date: 2018-03-07
Posted date: 2018-03-16
Communication number: 6034-422586 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- kathryn Nowers, Senior Policy Advisor | Minister of Health's Office | Health Canada (HC)
Subject Matter of the communication: Health, Industry
Communication date: 2017-12-07
Posted date: 2017-12-07
Communication number: 6034-414866 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bill Blair, Parliamentry Secretary | Health | House of Commons
Subject Matter of the communication: Health, Industry, Research and Development
Communication date: 2017-12-07
Posted date: 2017-12-07
Communication number: 6034-414864 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health Canada (HC)
- Pierre Sabourin, Assistant Deputy Minister | Health Canada (HC)
- Abby Hoffman, Assistant Deputy Minister | Health Canada (HC)
- Kendal Weber, Associate Assistant Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Research and Development, Economic Development
Communication date: 2017-11-14
Posted date: 2017-12-13
Communication number: 6034-415704 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sarah Hussaini, Policy | Prime Minister's office | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
Communication date: 2017-11-01
Posted date: 2017-11-03
Communication number: 6034-411215 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | ISED | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Intellectual Property, Research and Development, Economic Development
Communication date: 2017-11-01
Posted date: 2017-11-03
Communication number: 6034-411214 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry
Communication date: 2017-10-10
Posted date: 2017-10-23
Communication number: 6034-410559 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Frank Baylis, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Research and Development
Communication date: 2017-09-19
Posted date: 2017-09-22
Communication number: 6034-408338 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Corinne Guenette, Director, Life Science Industries, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Economic Development
Communication date: 2017-09-18
Posted date: 2017-09-22
Communication number: 6034-408339 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- douglas clark, Executive Director | Patented Medicines Pricing Review Board | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Economic Development
Communication date: 2017-08-03
Posted date: 2017-09-05
Communication number: 6034-407323 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Bill Blair, Member of Parliament, Scarborough Southwest | House of Commons | House of Commons
Subject Matter of the communication: Industry, Intellectual Property, Research and Development
Communication date: 2017-07-11
Posted date: 2017-08-11
Communication number: 6034-406575 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelly Gillis, Associate Deputy Minister | ISED | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development, Economic Development
Communication date: 2017-06-20
Posted date: 2017-07-18
Communication number: 6034-405909 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Research and Development, Economic Development
Communication date: 2017-05-23
Posted date: 2017-05-23
Communication number: 6034-401385 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Director General | Market Place Framework | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-01-30
Posted date: 2017-02-08
Communication number: 6034-393380 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Director General | Marketplace Framework Policy Branch, Strategic Policy Sector | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Intellectual Property
Communication date: 2016-11-17
Posted date: 2016-11-29
Communication number: 6034-389106 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry, Intellectual Property, Research and Development, Economic Development
Communication date: 2016-10-11
Posted date: 2016-11-14
Communication number: 6034-387639 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ian Foucher, Policy Advisor | Office of the Minister of Finance | Finance Canada (FIN)
Subject Matter of the communication: Intellectual Property
Communication date: 2016-06-10
Posted date: 2016-07-15
Communication number: 6034-381305 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Justin To, Policy Advisor | Office of the Prime Minister | Prime Minister's Office (PMO)
Subject Matter of the communication: Intellectual Property
Communication date: 2016-06-10
Posted date: 2016-07-15
Communication number: 6034-381302 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dev Saxena, Policy Advisor | Innovation, Science and Economic Development | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Intellectual Property
Communication date: 2016-06-10
Posted date: 2016-07-15
Communication number: 6034-381295 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Oliver, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Research and Development, Economic Development
Communication date: 2016-05-10
Posted date: 2016-05-24
Communication number: 6034-377669 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Celina Caesar-Chavannes, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Research and Development
Communication date: 2016-05-10
Posted date: 2016-05-24
Communication number: 6034-377668 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2016-05-09
Posted date: 2016-06-15
Communication number: 6034-377670 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rachael Harder, Member of Parliament | House of Commons
- Colin Carrie, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2016-05-03
Posted date: 2016-05-03
Communication number: 6034-375606 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Brian Clow, Chief of Staff | Global Affairs Canada (GAC)
- Sarah Husseini, Policy Advisor | Global Affairs Canada (GAC)
Subject Matter of the communication: Industry, Intellectual Property, International Trade, Economic Development
Communication date: 2016-04-13
Posted date: 2016-04-15
Communication number: 6034-374735 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Corinne Guenette, Director, Life Science Industries, Manufacturing and Life Sciences Branch | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, International Trade, Research and Development, Economic Development
Communication date: 2016-04-13
Posted date: 2016-04-15
Communication number: 6034-374733 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Len Webber, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2016-04-12
Posted date: 2016-05-03
Communication number: 6034-374204 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marco Mendicino, MP | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade, Research and Development
Communication date: 2016-04-07
Posted date: 2016-04-15
Communication number: 6034-374730 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marc Serre, MP | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade, Economic Development
Communication date: 2016-03-22
Posted date: 2016-04-15
Communication number: 6034-374725 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Terry Beech, Parliamentary Secretary | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Intellectual Property, International Trade, Taxation and Finance, Research and Development
Communication date: 2016-03-21
Posted date: 2016-04-15
Communication number: 6034-374722 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francois-Philippe Champagne, Parliamentary Secretary | Finance | Finance Canada (FIN)
Subject Matter of the communication: Industry, Intellectual Property, Research and Development, Economic Development
Communication date: 2016-03-07
Posted date: 2016-03-11
Communication number: 6034-371452 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Thomas Mulcair, Leader New Democratic Party | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade, Economic Development
Communication date: 2016-02-23
Posted date: 2016-03-11
Communication number: 6034-371448 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rona Ambrose, Leader of the Opposition | Opposition | House of Commons
Subject Matter of the communication: Industry, International Trade, Economic Development
Communication date: 2016-02-23
Posted date: 2016-03-11
Communication number: 6034-371443 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Earl Dreeshan, Vice-Chair | Standing Committee on Industry, Science and Technology | House of Commons
Subject Matter of the communication: Industry, Science and Technology, Research and Development, Economic Development
Communication date: 2016-02-23
Posted date: 2016-03-11
Communication number: 6034-371440 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tracey Ramsey, Critic | International Trade | House of Commons
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2016-02-23
Posted date: 2016-03-11
Communication number: 6034-371438 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Karen Vecchio, Critic | Families, Children and Social Development | House of Commons
Subject Matter of the communication: Industry, International Trade, Economic Development
Communication date: 2016-02-23
Posted date: 2016-03-15
Communication number: 6034-371435 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Terry Beech, Parliamentary Secretary | Science | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Industry, Research and Development, Economic Development
Communication date: 2016-02-23
Posted date: 2016-03-11
Communication number: 6034-371431 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Claude Poissant, Parliamentary Secretary | Agriculture and Agri-Food | Agriculture and Agri-Food Canada (AAFC)
Subject Matter of the communication: Industry, International Trade, Research and Development
Communication date: 2016-02-23
Posted date: 2016-03-11
Communication number: 6034-371429 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sarah Hussaini, Policy Advisor | International Trade | Global Affairs Canada (GAC)
- Simon Beauchemin, Special Assistant, Parliamentary Affairs | International Trade | Global Affairs Canada (GAC)
Subject Matter of the communication: Industry, Intellectual Property, Research and Development
Communication date: 2016-01-07
Posted date: 2016-02-15
Communication number: 6034-366601 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Deborah Levy, Chief of Staff | Office of the Minister of State (small business and tourism) | House of Commons
Subject Matter of the communication: Industry, Science and Technology
Communication date: 2014-09-29
Posted date: 2014-10-15
Communication number: 6034-335847 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Cynthia Tran, Advisor, Stakeholder Relations and Outreach | PMO | Prime Minister's Office (PMO)
- Virginie Bonneau, Regional Affairs Advisor, Quebec | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Industry, International Trade
Communication date: 2014-09-29
Posted date: 2014-10-15
Communication number: 6034-335843 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Laliberte, Policy Advisor | Office of the Minister of the Economic Development Agency for Quebec | House of Commons
Subject Matter of the communication: Industry, Science and Technology, Taxation and Finance
Communication date: 2014-09-25
Posted date: 2014-10-15
Communication number: 6034-335835 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Virginie Bonneau, Regional Affairs Advisor | Quebec | Prime Minister's Office (PMO)
Subject Matter of the communication: Industry
Communication date: 2014-07-23
Posted date: 2014-08-26
Communication number: 6034-332329 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dan Brown, Member of Parliament | House of Commons
Subject Matter of the communication: International Trade
Communication date: 2014-02-24
Posted date: 2014-03-15
Communication number: 6034-319372 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dan Harris, Memeber of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-02-18
Posted date: 2014-03-16
Communication number: 6034-319532 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eve Adams, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2014-01-09
Posted date: 2014-02-15
Communication number: 6034-316129 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Devinder Shory, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2013-12-04
Posted date: 2014-02-15
Communication number: 6034-316130 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Wilks, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2013-11-28
Posted date: 2013-12-15
Communication number: 6034-307911 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dany Morin, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2013-11-27
Posted date: 2013-12-03
Communication number: 6034-307910 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Art Eggleton, Senator | Senate of Canada
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2013-11-26
Posted date: 2013-12-15
Communication number: 6034-307912 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Chris Charlton, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2013-11-25
Posted date: 2013-12-03
Communication number: 6034-307909 (amended from 6034-307891) View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ron Cannan, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2013-11-18
Posted date: 2013-12-03
Communication number: 6034-307889 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dan Harris, Member of Parliament | House of Commons
Subject Matter of the communication: Health
Communication date: 2013-10-10
Posted date: 2013-12-03
Communication number: 6034-307929 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gary Goodyear, Minister of State | Office of the Minister of State | Federal Economic Development Agency for Southern Ontario (FedDev)
- Mark Schaan, Director, Pharmaceutical Policy | Life Science Industries Branch | Industry Canada
- Thomas Coughlan, Policy Advisor | Office of the Minister of State | Federal Economic Development Agency for Southern Ontario (FedDev)
Subject Matter of the communication: Health, Intellectual Property, Science and Technology
Communication date: 2013-04-23
Posted date: 2013-05-31
Communication number: 6034-275330 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gary Doer, Canada's Ambassador to the US | Canadian Trade Commission Service | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Health, Intellectual Property, International Trade
Communication date: 2013-03-05
Posted date: 2013-05-31
Communication number: 6034-275329 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dan Harris, Member of Parliament | Scarborough Southwest (Ontario) | House of Commons
Subject Matter of the communication: Intellectual Property, Science and Technology
Communication date: 2013-01-25
Posted date: 2013-04-16
Communication number: 6034-269836 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Policy Advisory | Minister's Office | Industry Canada
Subject Matter of the communication: Intellectual Property
Communication date: 2012-10-29
Posted date: 2012-11-15
Communication number: 6034-245083 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rick Stewart, Secretary to the Cabinet | Liaison Secretariat for Macroeconomic Policy | Privy Council Office (PCO)
- Sylvain Laporte, CEO, Commissioner of Patents | Canadian Intellectual Property Office | Industry Canada
- Chris Evans, Chair, Patents Appeals Board | Canadian Intellectual Property Office | Industry Canada
Subject Matter of the communication: Intellectual Property
Communication date: 2012-10-16
Posted date: 2012-11-15
Communication number: 6034-245019 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andre Bachand, Senior Advisor | Prime Minister's Office | Prime Minister's Office (PMO)
- Sean Speer, Senior Economic Policy Advisor | Prime Minister's Office | Prime Minister's Office (PMO)
- Andrea van Vugt, Policy Advisor | Foreign Affairs, Trade & International Development | Prime Minister's Office (PMO)
- Phil Harwood, Policy Advisor | Prime Minister's Office | Prime Minister's Office (PMO)
- Stefan Stefanov, Intern | Prime Minister's Office | Prime Minister's Office (PMO)
- Sean O'Leary, Policy Advisor | Ministry of Industry | Industry Canada
Subject Matter of the communication: Health, Industry, International Trade
Communication date: 2012-02-28
Posted date: 2012-04-26
Communication number: 6034-220327 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Karen Dodds, ADM | Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
Communication date: 2010-05-31
Posted date: 2010-08-03
Communication number: 6034-152959 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ron Parker, Senior ADM | Industry Sector | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology
Communication date: 2010-05-31
Posted date: 2010-08-03
Communication number: 6034-152958 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tony Clement, Minister of Industry | Industry Canada
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2010-05-04
Posted date: 2010-08-03
Communication number: 6034-152957 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Richard Discerni, Deputy Minister, Industry Canada | Industry Canada | Industry Canada
Subject Matter of the communication: Intellectual Property, Science and Technology, Taxation and Finance
Communication date: 2009-05-28
Posted date: 2009-07-06
Communication number: 6034-111876 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tony Clement, Industry Minister | Ministry of Industry | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade, Science and Technology, Taxation and Finance
Communication date: 2009-05-18
Posted date: 2009-07-06
Communication number: 6034-111874 View associated registration

Kenneth L Custer, President and General Manager (Corporation)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-133 of 133

Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yash Nanda, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2024-04-22
Posted date: 2024-05-15
Communication number: 6034-603127 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Michelle Ciesielski, Manager, Office of Patented Medicines and Liaison | Health Canada (HC)
- Anne Bowes, Director | Health Canada (HC)
- David Lee, Chief Regulatory Officer | Health Canada (HC)
- Paul Brogan, Market Director | Invest in Canada Hub
- Erin Campbell, Director | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2024-02-26
Posted date: 2024-03-15
Communication number: 6034-595827 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David Norris, Senior Trade Policy Officer | Global Affairs Canada (GAC)
- Loris Mirella, Director | Global Affairs Canada (GAC)
Subject Matter of the communication: Health
Communication date: 2024-01-31
Posted date: 2024-02-15
Communication number: 6034-592233 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Benoit Leduc, Manager | Innovation, Science and Economic Development Canada (ISED)
- Caroline Menard, Manager | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Rodrigo Arancibia, Director | Life Science Industries Directorate | Innovation, Science and Economic Development Canada (ISED)
- Ritu Banerjee, Assistant Deputy Minister | Director General's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2024-01-23
Posted date: 2024-02-15
Communication number: 6034-592232 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yash Nanda, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2024-01-23
Posted date: 2024-02-15
Communication number: 6034-592230 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eshan Naik, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2024-01-23
Posted date: 2024-02-15
Communication number: 6034-592192 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Brogan, Market Director | Invest in Canada Hub
- Abbigael Loomis , Investor Services Associate | Invest in Canada Hub
Subject Matter of the communication: Economic Development
Communication date: 2023-12-18
Posted date: 2024-01-15
Communication number: 6034-589882 View associated registration
Eli Lilly Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ophelia John, Senior Policy Advisor | Health Canada (HC)
- Eshan Naik, Director of Policy | Minister of Health | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2023-12-14
Posted date: 2024-01-15
Communication number: 6034-589881 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Senior Policy and Regional Affairs Advisor Natural Resources Canada, Minister's Office	August 2012 to November 2015	November 30, 2015
Director of Policy Public Works and Government Services Canada, Minister's Office	December 2009 to August 2012	August 3, 2012
Policy Advisor Employment and Social Development Canada - Labour Program, Minister's Office	May 2009 to December 2009	December 1, 2009
Senior Special Assistant Western Economic Diversification, Minister's Office	August 2007 to April 2009	April 30, 2009
Parliamentary Assistant House of Commons of Canada, MP Office	September 2006 to August 2007	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Eli Lilly Canada Inc. / Kenneth L Custer, President and General Manager

Registration Information

Associated Communications

Version 33 of 34 (2024-02-01 to 2024-05-13)

Version 33 of 34 (2024-02-01 to 2024-05-13)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution

Policies or Program

Regulation

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties